37447241|t|Therapeutic Potential of Bioactive Compounds from Brugmansia suaveolens Bercht. & J. Presl.
37447241|a|Brugmansia suaveolens Bercht. & J. Presl has been widely used due to the presence of different bioactive compounds. This review summarizes the latest advances and perspectives of the B. suaveolens plant species; it is a systematic literature review on aspects of botany, traditional uses, phytochemistry, pharmacology, and toxicology as therapeutic potential. In addition, 120 compounds are described, including alkaloids, flavonoids, terpenoids, steroids, amino acids, aromatics, and aliphatics. As for the therapeutic potential, it is described in extracts and compounds in the antitumor, anti-inflammatory, antioxidant, antimicrobial, antispasmodic, anticoagulant, and analgesic aspects, as well as the effects on the central nervous system. The toxicity of the genus stands out, especially the potential for organ toxicity. Therefore, this review evidenced the knowledge related to the traditional use based on the scientific research of Brugmansia suaveolens, highlighting an overview of bioactive compounds and biological and toxicological activities in order to provide a scientific basis for future studies on the value of this species for the development of new natural products.
37447241	85	90	Presl	Chemical	-
37447241	92	113	Brugmansia suaveolens	Disease	
37447241	127	132	Presl	Chemical	-
37447241	504	513	alkaloids	Chemical	MESH:D000470
37447241	515	525	flavonoids	Chemical	MESH:D005419
37447241	527	537	terpenoids	Chemical	MESH:D013729
37447241	539	547	steroids	Chemical	MESH:D013256
37447241	688	700	inflammatory	Disease	MESH:D007249
37447241	841	849	toxicity	Disease	MESH:D064420
37447241	910	918	toxicity	Disease	MESH:D064420

